A research-led pharmaceutical company engaged in developing, manufacturing, and marketing generic finished dosage formulations alongside specialized oncology products. Established in 1993, the company operates across India's healthcare sector, delivering affordable medications to patients nationwide. Its distinctive positioning combines robust generic drug production capabilities with focused expertise in oncology therapeutics, serving both domestic markets and international customers through quality-driven operations.
Get the next move the moment it happens.
Follow the investors and Medicamen Biotech Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
